Product Description
Auto-retarctable Safety Syringe is a kind of syringe which has a safety mechanism built into the syringe. The needle on auto-retarctable safety syringe can be detachable or permanently attached. On some models, a sheath is placed over the needle or the needle retracts into the barrel following injection to protect healthcare workers and others from accidental needlestick injuries.
The Auto-Retractable Safety Syringe market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Auto-Retractable Safety Syringe market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Auto-Retractable Safety Syringe Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Auto-Retractable Safety Syringe market are:
Globe Medical Tech
DMC Medical
Medicina
Mediprim
Medtronic
BD
Haiou Medical
Retractable Technologies
Q Stat
Revolutions Medical
Most important types of Auto-Retractable Safety Syringe products covered in this report are:
0.5 ml
1 ml
3 ml
5 ml
Others
Most widely used downstream fields of Auto-Retractable Safety Syringe market covered in this report are:
Intravenous (IV)
Intramuscular (IM)
Subcutaneous (Sub-Q)
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.